Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(2.83)
# 1,650
Out of 5,113 analysts
5
Total ratings
60%
Success rate
50.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma | Initiates: Buy | $4 | $0.36 | +998.00% | 1 | Aug 25, 2025 | |
| IRD Opus Genetics | Initiates: Buy | $5 | $2.81 | +77.94% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $15.65 | +53.35% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $2.15 | +179.07% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $5.22 | +149.04% | 1 | Dec 17, 2024 |
Cue Biopharma
Aug 25, 2025
Initiates: Buy
Price Target: $4
Current: $0.36
Upside: +998.00%
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $2.81
Upside: +77.94%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $15.65
Upside: +53.35%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $2.15
Upside: +179.07%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $5.22
Upside: +149.04%